Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Maj 2023

Genmab — Maj 2023

Planlagt Fastgjort Låst Flyttet Genmab
490 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    ProinvestorNEWS
    wrote on sidst redigeret af
    #71

    Genmab/CEO: Nyt kræfthåb kan lanceres i løbet af uger
    https://www.proinvestor.com/investornyt/983366/genmab-ceo-nyt-kraefthab-kan-lanceres-i-lobet-af-uger

    1 Reply Last reply
    0
    • J Offline
      J Offline
      JKY_VH
      wrote on sidst redigeret af
      #72

      "Biotekselskabet Genmab får løftet kursmålet til 3022 kr. fra 2798 kr. af finanshuset Cowen, der fastholder den neutrale anbefaling “market perform”.

      Det viser data fra Bloomberg News."

      1 Reply Last reply
      0
      • J Offline
        J Offline
        JKY_VH
        wrote on sidst redigeret af
        #73

        Nordea sænker kursmålet en smule ". We are at the very top of the company's guidance ranges. Our estimates are trimmed by 1-3% from 2023-25, mainly owing to a lower USD in the model. We remain buyers with a lower DCF-derived target price of DKK 3,030 (3,060).KEY INFODKK 3,030 Target priceDKK 2,832 Fair ValueDKK 2,733 Share price, closeAANordea ESG ratingGMAB DCBloombergGMAB.COReuters100%Free FloatEUR 24.19/DKK 180.27Market cap. (bn)www.genmab.comCompany website03 Aug 2023Next report dateNordea I

        1 Reply Last reply
        0
        • P Offline
          P Offline
          ProinvestorNEWS
          wrote on sidst redigeret af
          #74

          Genmabs amerikanske notering peger mod flad åbning https://www.proinvestor.com/investornyt/983389/genmabs-amerikanske-notering-peger-mod-flad-abning

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #75

            https://seekingalpha.com/article/4602758-genmab-s-gmab-q1-2023-earnings-call-transcript Genmab A/S (GMAB) Q1 2023 Earnings Call Transcript

            1 Reply Last reply
            0
            • DarvinD Offline
              DarvinD Offline
              Darvin
              wrote on sidst redigeret af
              #76

              Jefferiesforhøjer fra 2850til 2900

              1 Reply Last reply
              0
              • DarvinD Offline
                DarvinD Offline
                Darvin
                wrote on sidst redigeret af
                #77

                Goldman Sachs “regulerer” med 31 point fra 2688 til 2657 😉 uændret ellers

                1 Reply Last reply
                0
                • DarvinD Offline
                  DarvinD Offline
                  Darvin
                  wrote on sidst redigeret af
                  #78

                  OG Moskovien er fortsat påvej til at finde sin rette beskedne plads i verden, og Putin mangler nu gift til sine modstandere. Mangel på Novichok
                  😉

                  1 Reply Last reply
                  0
                  • D Offline
                    D Offline
                    deleted-user
                    wrote on sidst redigeret af
                    #79

                    Som jeg forsøgte, at fremhæve i går. Opex lå i interval og dermed ingen overraskelse, hvis man havde gjort sig umage og sammenholdt med budget.

                    1 Reply Last reply
                    0
                    • J Offline
                      J Offline
                      JKY_VH
                      wrote on sidst redigeret af
                      #80

                      Korrekt LLi;-)

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #81

                        can anyone clarify this, what Jan said on Hexabody-CD38 "And also in the context of IRA legislation and complexity from that perspective, it could be very smart for Janssen to actually switch at some point, DARZALEX for a next-generation CD38 targeted medicines." ?

                        1 Reply Last reply
                        0
                        • D Offline
                          D Offline
                          deleted-user
                          wrote on sidst redigeret af
                          #82

                          No Sry EL. I just noted that Winkel appeared fairly sure that JJ at some point will grab the opt That was enough for me in accordance to my lacking understanding (:-))

                          1 Reply Last reply
                          0
                          • BulderB Offline
                            BulderB Offline
                            Bulder
                            wrote on sidst redigeret af
                            #83

                            Which probably means that they already now know enough about hex38 data.

                            1 Reply Last reply
                            0
                            • BulderB Offline
                              BulderB Offline
                              Bulder
                              wrote on sidst redigeret af
                              #84

                              Unfortunately the cc transcript is locked. Anything important?

                              1 Reply Last reply
                              0
                              • BulderB Offline
                                BulderB Offline
                                Bulder
                                wrote on sidst redigeret af
                                #85

                                Lidt overraskende, at den stiger så pænt når nu omkostningerne “skuffer”.

                                1 Reply Last reply
                                0
                                • D Offline
                                  D Offline
                                  deleted-user
                                  wrote on sidst redigeret af
                                  #86

                                  Ja det var sort snak. Nogen læste blot ændringen fra Q4 22 til Q1 23 og så griber den konklusion hurtigt om sig og skaber markedets "forståelse"...... Jeg forsøgte mit bedste 😉

                                  1 Reply Last reply
                                  0
                                  • D Offline
                                    D Offline
                                    deleted-user
                                    wrote on sidst redigeret af
                                    #87

                                    Vi ramte ret præcist Tellers' interval fraregnet fortegn

                                    1 Reply Last reply
                                    0
                                    • D Offline
                                      D Offline
                                      deleted-user
                                      wrote on sidst redigeret af
                                      #88

                                      I øvrigt - Winkel lød også meget positiv for at både 1042 og 1046 kører videre

                                      1 Reply Last reply
                                      0
                                      • BulderB Offline
                                        BulderB Offline
                                        Bulder
                                        wrote on sidst redigeret af
                                        #89

                                        9:48, herregud, en streg fra eller til 🙂

                                        1 Reply Last reply
                                        0
                                        • StockBullS Offline
                                          StockBullS Offline
                                          StockBull
                                          wrote on sidst redigeret af
                                          #90

                                          Ja det ser godt ud. Positivt at der kommer opjusteringer. Dog kun nogle få som har target over 3000. Men det kommer måske efter Epco godkendelsen

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper